Advertisement

Topics

Reviewing Myriad Genetics

19:14 EDT 29 Jul 2017 | Topix

Myriad Genetics and Cepheid are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, dividends, risk, profitabiliy, institutional ownership and earnings. 95.8% of Cepheid shares are owned by institutional investors.

Original Article: Reviewing Myriad Genetics

NEXT ARTICLE

More From BioPortfolio on "Reviewing Myriad Genetics"

Quick Search
Advertisement